Phase 3 Pneumococcal Immunization Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Healthy VolunteersPneumococcal Immunization
Sanofi2,195 enrolled6 locationsNCT07348692
Recruiting
Phase 3
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
Pneumococcal Immunization
Sanofi2,320 enrolled134 locationsNCT06824194